"
Efficacy of Palmitoylethanolamide (Levagen+TM) Compared to Ibuprofen for Reducing Headache Pain Severity and Duration in Healthy Adults: A Double-Blind, Parallel, Randomized Clinical Trial"
written by David Briskey, Phillippa Ebelt, Elizabeth Steels, Silma Subah, Nathasha Bogoda, Amanda Rao,
published by
Food and Nutrition Sciences,
Vol.13 No.7, 2022
has been cited by the following article(s):
|
[1]
|
Mechanisms and clinical applications of palmitoylethanolamide (PEA) in the treatment of neuropathic pain
Inflammopharmacology,
2025
DOI:10.1007/s10787-024-01623-8
|
|
|
|
|
[2]
|
The Effect of Palmitoylethanolamide (PEA) on Skeletal Muscle Hypertrophy, Strength, and Power in Response to Resistance Training in Healthy Active Adults: A Double-Blind Randomized Control Trial
Sports Medicine - Open,
2024
DOI:10.1186/s40798-024-00732-6
|
|
|
|
|
[3]
|
Efficacy of Topical Palmitoylethanolamide (Levagen+) for the Management of Eczema Symptoms: A Double-Blind, Comparator-Controlled, Randomized Clinical Trial
Skin Pharmacology and Physiology,
2023
DOI:10.1159/000536670
|
|
|
|
|
[4]
|
Efficacy of Topical Palmitoylethanolamide (Levagen+) for the Management of Eczema Symptoms: A Double-Blind, Comparator-Controlled, Randomized Clinical Trial
Skin Pharmacology and Physiology,
2023
DOI:10.1159/000536670
|
|
|
|